FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)

View source ↗

Summary

FDA approves a supplemental NDA for Allegra-D Allergy and Congestion, submitted by Chattem, Inc., concerning fexofenadine hydrochloride and pseudoephedrine hydr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• ALLEGRA-D ALLERGY AND CONGESTION (Fexofenadine hydrochloride and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ALLEGRA-D ALLERGY AND CONGESTION (FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE)